Global Neurology Academy - Global Neurology Academy

Global Neurology Academy

Global Neurology Academy

Enhance your practice with CME
and tools that focus on the management
of neurological conditions.

Popular

Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CE Broadcast Replay
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS; Valeria Caso, MD, PhD
0.75 credits
- C. Michael Gibson, MD, MS
- Valeria Caso, MD, PhD
- Ashkan Shoamanesh, MD
0.75 credits
Precision Medicine for Myasthenia Gravis
Precision Medicine for Myasthenia Gravis
NeuroFrontiers
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Discharge Planning After Myasthenic Crisis
Discharge Planning After Myasthenic Crisis
NeuroFrontiers
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
- Qihua Fan, MD
Outcome Measures Capture Progression in Late-Onset TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
NeuroFrontiers
Outcome Measures Capture Progression in Late-Onset TK2d
ADHD Is Linked to a Broad Burden of GI Symptoms
ADHD Is Linked to a Broad Burden of GI Symptoms
NeuroFrontiers
ADHD Is Linked to a Broad Burden of GI Symptoms
ADHD After 25 Years: What Have We Learned?
ADHD After 25 Years: What Have We Learned?
NeuroFrontiers
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
- James Swanson, PhD
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
NeuroFrontiers
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Jill RachBeisel, MD
- Jill RachBeisel, MD
Diagnosing Adult ADHD in the Social Media Era
Diagnosing Adult ADHD in the Social Media Era
NeuroFrontiers
Diagnosing Adult ADHD in the Social Media Era
Jill RachBeisel, MD
- Jill RachBeisel, MD

Medical News

Medical News
Race, Stroke Belt, and Cerebral Microbleeds After Stroke
10/05/2026
Read more
Medical News
Parkinson's AI Chatbot Misses Critical Safety Errors
10/01/2026
Read more
Medical News
Japanese Study Reveals Treatment‐Resistant Schizophrenia Prevalence in Inpatients
09/29/2026
Read more
Medical News
MRgFUS Thalamotomy Improves Parkinson Tremor at 6 Months
09/23/2026
Read more

CME/CE

CME/CE In-Person Event
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
1.00 credit
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast Replay
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD; David Weisman, MD
1.00 credit
- Dani Cabral, MD
- David Weisman, MD
1.00 credit
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
MinuteCE®
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
MinuteCE®
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits

Clinical Practice

The New Era of Targeted Therapy for Myasthenia Gravis
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiers
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiers
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
More Than a Myopathy: The Lived Experience of TK2d
More Than a Myopathy: The Lived Experience of TK2d
NeuroFrontiers
More Than a Myopathy: The Lived Experience of TK2d
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
NeuroFrontiers
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class

Programs

Navigating Emerging Treatment Options in MG
Navigating Emerging Treatment Options in MG
NeuroFrontiers
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
- Qihua Fan, MD
What’s Still Missing in ADHD Care?
What’s Still Missing in ADHD Care?
NeuroFrontiers
What’s Still Missing in ADHD Care?
James Swanson, PhD
- James Swanson, PhD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Recurrence as the Rule: BD Symptoms Persist and Cycle
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits